Empaa-M Xr Tab 12.5mg/1000mg is a specially developed medication for managing type 2 diabetes mellitus. These extended-release tablets combine the power of Metformin hydrochloride and Empagliflozin to effectively improve glucose tolerance. Metformin works to lower plasma glucose levels by reducing hepatic glucose production and enhancing insulin sensitivity. Empagliflozin, an SGLT2 inhibitor, aids in increasing urinary glucose excretion, further promoting glucose control. This combination offers a comprehensive approach to managing diabetes by targeting multiple pathways. This tab is designed to provide convenient and effective treatment, helping individuals achieve better control over their diabetes. Experience the benefits of this advanced formula for enhanced glucose management and improved quality of life.